VIDEO: Hybrid Complete Health Improvement Program feasible for patients with type 2 diabetes
Click Here to Manage Email Alerts
ORLANDO — A pilot study found a hybrid online/in-person version of the Complete Health Improvement Program could be feasible for patients with type 2 diabetes, according to a poster presented at the Lifestyle Medicine Conference.
The Complete Health Improvement Program (CHIP) has previously been shown to improve biometrics and reduce drug utilization in this patient population; however, these studies were conducted prior to online program availability.
Thomas B. Morland, MD, a general internist at Geisinger Health, and colleagues conducted this pilot feasibility study, which offered 12 weeks of CHIP classes allowing for remote participation.
They found the program to be feasible at their institution, leading to the conclusion that a full trial should be helpful to determine if hybrid CHIP programs could have a larger impact on patients with type 2 diabetes.